Literature DB >> 10930393

Barrett's esophagus: an overrated cancer risk factor.

S J Spechler.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10930393     DOI： 10.1053/gast.2000.9849

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

1.  Antagonist: endoscopic surveillance of patients with Barrett's oesophagus.

Authors:  R J Playford
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

2.  Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus.

Authors:  S H Doak; G J S Jenkins; E M Parry; F R D'Souza; A P Griffiths; N Toffazal; V Shah; J N Baxter; J M Parry
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

3.  The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort.

Authors:  B T Theron; H Padmanabhan; H Aladin; P Smith; E Campbell; P Nightingale; B T Cooper; N J Trudgill
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

4.  Dysplasia in Barrett's Esophagus.

Authors:  Marcos Pedrosa
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

5.  Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

Authors:  R C Fitzgerald; S Abdalla; B A Onwuegbusi; P Sirieix; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

6.  Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda.

Authors:  Ponsiano Ocama; Magid M Kagimu; Michael Odida; Henry Wabinga; Christopher K Opio; Britt Colebunders; Sabrina van Ierssel; Robert Colebunders
Journal:  Afr Health Sci       Date:  2008-06       Impact factor: 0.927

7.  A case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer Study.

Authors:  Petra H Lahmann; Torukiri I Ibiebele; Penelope M Webb; Christina M Nagle; David C Whiteman
Journal:  BMC Cancer       Date:  2014-11-24       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.